Zimmer Biomet Holdings, Inc. (BIT:1ZBH)

Market Cap	16.27B
Revenue (ttm)	7.12B
Net Income (ttm)	845.08M
Shares Out	n/a
EPS (ttm)	4.17
PE Ratio	19.25
Forward PE	11.96
Dividend	0.89 (1.11%)
Ex-Dividend Date	Mar 28, 2025

Volume	n/a
Average Volume	n/a
Open	n/a
Previous Close	80.00
Day's Range	n/a
52-Week Range	77.72 - 90.38
Beta	n/a
RSI	51.01
Earnings Date	Aug 4, 2025

About Zimmer Biomet Holdings

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open hear...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1927
• Employees: 17,000
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1ZBH

Financial Performance

In 2024, Zimmer Biomet Holdings's revenue was $7.68 billion, an increase of 3.85% compared to the previous year's $7.39 billion. Earnings were $903.80 million, a decrease of -11.74%.

Financial numbers in USD